{"preliminary_commentary":{"by_channel":{"x_thread":3,"youtube":2,"podcast":2},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":false},"commentary_summary":null,"drugs_tested":[["iopofosine I-131 (CLR 131)"]],"indication":"relapsed or refractory select B-cell malignancies","name":"CLOVER-1","nct_id":"NCT02952508","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=clover-1-nct02952508. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"CLOVER-WaM","arms":[{"description":"Iopofosine I 131 in Waldenstroms Macroglobulinemia","label":"Iopofosine I 131, intravenous administration WM","type":"EXPERIMENTAL"},{"description":"Iopofosine I 131 in Multiple Myeloma","label":"Iopofosine I 131, intravenous administration MM","type":"EXPERIMENTAL"},{"description":"Iopofosine I 131 in Central Nervous System Lymphoma","label":"Iopofosine I 131, intravenous administration CNS Lymphoma","type":"EXPERIMENTAL"},{"description":"Iopofosine I 131 in Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, and Diffuse Large B-Cell Lymphoma","label":"Iopofosine I 131 intravenous administration NHL [CLOSED]","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2027-12-22","type":"ESTIMATED"},"conditions":["Waldenstrom Macroglobulinemia","Multiple Myeloma","Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma","Lymphoplasmacytic Lymphoma","Marginal Zone Lymphoma","Mantle Cell Lymphoma","Diffuse Large B Cell Lymphoma","Central Nervous System Lymphoma"],"enrollment":{"count":120,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Iopofosine I 131 single dose","otherNames":["I-131-CLR1404","CLR 131"],"type":"DRUG"},{"name":"Iopofosine I 131 multiple dose","otherNames":["I-131-CLR1404","CLR 131"],"type":"DRUG"},{"name":"Iopofosine I 131 fractionated dose","otherNames":["I-131-CLR1404","CLR 131"],"type":"DRUG"}],"last_update":"2026-03-18","lead_sponsor":"Cellectar Biosciences, Inc.","official_title":"An Open-Label, Multicenter, Phase 2 Study of Iopofosine I 131 (CLR 131) in Patients With Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients With Waldenstrom Macroglobulinemia (CLOVER-WaM)","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2026-06-22","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Part A [CLOVER-1] Clinical benefit rate","timeFrame":"84 days"},{"measure":"Part B [CLOVER-WaM] Major Response Rate","timeFrame":"12 months"}],"references":[],"start_date":{"date":"2017-07-26","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom","url":"https://clinicaltrials.gov/study/NCT02952508"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.1","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/clover-1-nct02952508"}